NCT04800653

Brief Summary

Postoperative delirium is an acute state of confusion, which is characterized by changes in attention and cognitive functions and fluctuations in consciousness; postoperative cognitive dysfunction is a common central nervous system complication in elderly patients after surgery, often manifested as memory, Obstacles in abstract thinking and orientation are accompanied by a decline in social activity ability. Postoperative delirium and cognitive dysfunction can prolong hospital stay, increase medical expenses, affect postoperative functional recovery, and even increase postoperative mortality. Sleep disorders are a group of diseases that affect the ability to sleep well regularly and cause severe impairment of social and occupational functions. Stellate ganglion block is a selective sympathetic ganglion block, in which a local anesthetic is injected into the loose connective tissue of the neck including the stellate ganglion. There are complex connections between stellate ganglia and multiple brain regions in the brain, which can improve postoperative delirium, cognitive function and sleep disturbance to a certain extent, and have certain guiding significance for postoperative rehabilitation of elderly patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 11, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 16, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2022

Completed
Last Updated

October 24, 2022

Status Verified

October 1, 2022

Enrollment Period

1 year

First QC Date

March 11, 2021

Last Update Submit

October 21, 2022

Conditions

Keywords

DeliriumCognitive DysfunctionSleep Disorders

Outcome Measures

Primary Outcomes (3)

  • Changes in the level of Mini-Men-tal State Examination scale score

    Assess the cognitive function of the patient by asking questions on the patient scale

    The day before surgery and 1,2,3,5,7 days after surgery

  • Changes in the level of actigraphy

    Through the actigraphy, monitor the patient's sleep quality

    The 1st night before the operation and the 1st, 2nd and 3rd nights postoperatively

  • Changes in the level of Pittsburgh sleep quality index

    Assess the patient's sleep quality by asking questions on the scale

    The day before surgery and 1,2,3,5,7 days

Secondary Outcomes (10)

  • Changes in the level of IL-1

    Preoperative, 6 am on the first day after surgery, 6 am on the third day after surgery

  • Changes in the level of Systolic Blood Pressure/Diastolic Blood Pressure(Mean Arterial Pressure)

    Baseline (Before induction), immediately before intubation, immediately after intubation, at the beginning of the operation, 1 hour after the beginning of the operation, and immediately after extubation at the end of the operation

  • Local cerebral Oxygen Saturation

    Collected every 15 minutes before induction of anesthesia to 1 hour after the end of anesthesia

  • Changes in the level of IL-10

    Preoperative, 6 am on the first day after surgery, 6 am on the third day after surgery

  • Changes in the level of IL-6

    Preoperative, 6 am on the first day after surgery, 6 am on the third day after surgery

  • +5 more secondary outcomes

Study Arms (2)

Stellate ganglion block

EXPERIMENTAL

Before the operation, the left stellate ganglion block was performed, and 0.375% ropivacaine 5ml was injected into the stellate ganglion.

Procedure: Stellate ganglion block

Control

NO INTERVENTION

Do nothing

Interventions

Find the position of the stellate ganglion under ultrasound guidance, and inject 0.375% ropivacaine near the stellate ganglion to block the sympathetic nerves in the upper chest and head and neck

Stellate ganglion block

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 60 years;
  • ASA grade I-III;
  • Operative time ≥ 2 h for laparoscopic radical resection of a suspected; gastrointestinal malignancy.

You may not qualify if:

  • Patient's lack of consent to participate;
  • Known allergy to anesthetic drugs;
  • History of psychiatric or neurological disease(s);
  • Long-term use of opioids or sedative-hypnotic drugs;
  • Previous or planned neurosurgical procedures;
  • contraindications to epidural anesthesia;
  • Hearing or visual impairment that precludes scale assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Affiliated Hospital of Yangzhou University

Yangzhou, Jiangsu, China

Location

Related Publications (1)

  • Yan S, Wang Y, Yu L, Xia W, Xue F, Yu Y, Yuan B, Li N, Li H, Liang H, Ma J, Zhang Z. Stellate ganglion block alleviates postoperative sleep disturbance in patients undergoing radical surgery for gastrointestinal malignancies. J Clin Sleep Med. 2023 Sep 1;19(9):1633-1642. doi: 10.5664/jcsm.10632.

MeSH Terms

Conditions

DeliriumCognitive DysfunctionSleep Wake Disorders

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersCognition Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

March 11, 2021

First Posted

March 16, 2021

Study Start

March 1, 2021

Primary Completion

March 1, 2022

Study Completion

July 12, 2022

Last Updated

October 24, 2022

Record last verified: 2022-10

Locations